Emotional Intelligence Ventures, a company looking to develop a botanical approach to psychedelic medicines, announced that its Reg A has reached a milestone of $20 million.
The Hawaii-based company announced a $50 million public stock offering using the Reg A+ Framework in March. This type of offering allows retail investors and the general public (not just institutional and accredited investors) to take positions in the company before a public listing.
“I’m really passionate about democratizing investment opportunities so any investor can reap the rewards, and take all of the risks of early investment in game-changing companies,” said David Nikzad, founder and CEO of Ei.Ventures.
In August, the company announced a partnership with Tioga Research to develop a transdermal patch for sustained delivery of psilocin, the active ingredient in psilocybin mushrooms, for mental health applications.
The company also plans to launch a line of functional mushrooms, called “MANA nutraceuticals,” in early 2022.
Photo by Artur Kornakov on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!